Fiomi Diagnostics AB develops and manufacture Meritas® POC Analyzer
With its current and future menu of tests, sets a new standard for point-of-care testing, including the only guideline- compliant POC Troponin assay – the Meritas® Troponin I test. This allows fast, cost-effective and accurate triage, enabling rapid intervention for improved patient outcomes.
Fiomi Diagnostics AB is a wholy owned subsidiary of Trinity Biotech plc.
Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.
Fiomi Diagnostics AB
Dag Hammarskjölds väg 52A
SE-751 83 Uppsala
Tel: +46 18 56 08 90
Fax: +46 18 55 20 90